TY  - JOUR
PY  - 2019//
TI  - A pilot randomized controlled trial of cognitive behavioral treatment for trauma-related nightmares in active duty military personnel
JO  - Journal of clinical sleep medicine
A1  - Pruiksma, Kristi E.
A1  - Taylor, Daniel J.
A1  - Mintz, Jim
A1  - Nicholson, Karin L.
A1  - Rodgers, Matthew
A1  - Young-McCaughan, Stacey
A1  - Hall-Clark, Brittany N.
A1  - Fina, Brooke A.
A1  - Dondanville, Katherine A.
A1  - Cobos, Briana
A1  - Wardle-Pinkston, Sophie
A1  - Litz, Brett T.
A1  - Roache, John D.
A1  - Peterson, Alan L.
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - STUDY OBJECTIVES: The aim of this study was to obtain preliminary data on the efficacy, credibility, and acceptability of Exposure, relaxation, and rescripting therapy for military service members and veterans (ERRT-M) in active duty military personnel with trauma-related nightmares. <br><br>METHODS: Forty participants were randomized to either 5 sessions of ERRT-M or 5 weeks of minimal contact control (MCC) followed by ERRT-M. Assessments were completed at baseline, posttreatment/postcontrol, and 1-month follow-up. <br><br>RESULTS: Differences between ERRT-M and control were generally medium in size for nightmare frequency (Cohen <i>d = -</i>0.53), nights with nightmares (<i>d =</i> -0.38), nightmare severity (<i>d = -</i>0.60), fear of sleep (<i>d =</i> -0.44), and symptoms of insomnia (<i>d =</i> -0.52), and depression (<i>d =</i> -0.51). In the 38 participants who received ERRT-M, there were statistically significant, medium-sized decreases in nightmare frequency (<i>d</i> = -0.52), nights with nightmares (<i>d</i> = -0.50), nightmare severity (<i>d</i> = -0.55), fear of sleep (<i>d</i> = -0.48), and symptoms of insomnia (<i>d</i> = -0.59), posttraumatic stress disorder (PTSD) (<i>d</i> = -0.58) and depression (<i>d</i> = -0.59) from baseline to 1-month follow-up. Participants generally endorsed medium to high ratings of treatment credibility and expectancy. The treatment dropout rate (17.5%) was comparable to rates observed for similar treatments in civilians. <br><br>CONCLUSIONS: ERRT-M produced medium effect-size reductions in nightmares and several secondary outcomes including PTSD, depression, and insomnia. Participants considered ERRT-M to be credible. An adequately powered randomized clinical trial is needed to confirm findings and to compare ERRT-M to an active treatment control. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; Title: A Pilot Randomized Controlled Trial of Treatment for Trauma-Related Nightmares In Active Duty Military Personnel; Identifier: NCT02506595; URL: https://clinicaltrials.gov/ct2/show/NCT02506595.<br><br>© 2019 American Academy of Sleep Medicine.<p />  <p>Language: en</p>
LA  - en
SN  - 1550-9389
UR  - http://dx.doi.org/
ID  - ref1
ER  -